Indian benchmark indices settled sharply lower on Friday on the back of weak global cues due to geopolitical concerns and consistent foreign outflows. Market is on risk aversion mode after Israel’s military strike on Iran. BSE Sensex tanked 573.38 points, or 0.70 per cent, to settle at 81,118.60, while NSE's Nifty50 plunged 169.60 points, or 0.68 per cent to close at 24,718.60 for the day.
Select buzzing stocks including Glenmark Pharmaceuticals Ltd, Valor Estate Ltd (D B Realty Ltd) and Max Healthcare Institute Ltd are likely to remain under the spotlight of traders for the session today. Here is what analysts at Axis Securities have to say about these stocks ahead of Monday's trading session:
Valor Estate | Buy | Target Price: Rs 266-275 | Stop Loss: 208
Valor Estate (formerly known as DB Realty) has delivered a decisive breakout above the multiple resistance zone near Rs 235 on the weekly chart, confirmed by a strong bullish candle, signalling the start of a medium-term uptrend. Surge in volume during the breakout underscores robust market participation, adding conviction to the validity of the breakout. A weekly close above the upper Bollinger Band has triggered a fresh technical buy signal, pointing to strengthening bullish undertones. Both daily and weekly RSI are holding above their respective reference lines, reinforcing a positive. Analysis indicates an upside potential toward Rs 266-275 levels.
SOURCE-Business Today
#StockMarket #Investing #GlenmarkPharma #MaxHealthcare #ValorEstate #AxisSecurities #StockTips #ShareMarketIndia #PharmaStocks #HealthcareStocks
Select buzzing stocks including Glenmark Pharmaceuticals Ltd, Valor Estate Ltd (D B Realty Ltd) and Max Healthcare Institute Ltd are likely to remain under the spotlight of traders for the session today. Here is what analysts at Axis Securities have to say about these stocks ahead of Monday's trading session:
Valor Estate | Buy | Target Price: Rs 266-275 | Stop Loss: 208
Valor Estate (formerly known as DB Realty) has delivered a decisive breakout above the multiple resistance zone near Rs 235 on the weekly chart, confirmed by a strong bullish candle, signalling the start of a medium-term uptrend. Surge in volume during the breakout underscores robust market participation, adding conviction to the validity of the breakout. A weekly close above the upper Bollinger Band has triggered a fresh technical buy signal, pointing to strengthening bullish undertones. Both daily and weekly RSI are holding above their respective reference lines, reinforcing a positive. Analysis indicates an upside potential toward Rs 266-275 levels.
SOURCE-Business Today
#StockMarket #Investing #GlenmarkPharma #MaxHealthcare #ValorEstate #AxisSecurities #StockTips #ShareMarketIndia #PharmaStocks #HealthcareStocks
Indian benchmark indices settled sharply lower on Friday on the back of weak global cues due to geopolitical concerns and consistent foreign outflows. Market is on risk aversion mode after Israel’s military strike on Iran. BSE Sensex tanked 573.38 points, or 0.70 per cent, to settle at 81,118.60, while NSE's Nifty50 plunged 169.60 points, or 0.68 per cent to close at 24,718.60 for the day.
Select buzzing stocks including Glenmark Pharmaceuticals Ltd, Valor Estate Ltd (D B Realty Ltd) and Max Healthcare Institute Ltd are likely to remain under the spotlight of traders for the session today. Here is what analysts at Axis Securities have to say about these stocks ahead of Monday's trading session:
Valor Estate | Buy | Target Price: Rs 266-275 | Stop Loss: 208
Valor Estate (formerly known as DB Realty) has delivered a decisive breakout above the multiple resistance zone near Rs 235 on the weekly chart, confirmed by a strong bullish candle, signalling the start of a medium-term uptrend. Surge in volume during the breakout underscores robust market participation, adding conviction to the validity of the breakout. A weekly close above the upper Bollinger Band has triggered a fresh technical buy signal, pointing to strengthening bullish undertones. Both daily and weekly RSI are holding above their respective reference lines, reinforcing a positive. Analysis indicates an upside potential toward Rs 266-275 levels.
SOURCE-Business Today
#StockMarket #Investing #GlenmarkPharma #MaxHealthcare #ValorEstate #AxisSecurities #StockTips #ShareMarketIndia #PharmaStocks #HealthcareStocks
